Literature DB >> 32984893

Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population.

Brian B Løgstrup1, Torkell Ellingsen2,3, Alma B Pedersen4, Bianka Darvalics4, Kevin K W Olesen1, Hans Erik Bøtker1, Michael Maeng1.   

Abstract

OBJECTIVES: To compare risk of cardiovascular disease and mortality in patients with incident RA, diabetes mellitus (DM) and the general population (GP).
METHODS: Patients diagnosed with incident RA were matched 1:5 by age, sex and year of RA diagnosis with the GP. In the same period, patients with incident DM were included. Outcomes were heart failure (HF), myocardial infarction (MI), coronary revascularization, stroke, major adverse cardiovascular events (MACE) and death up to 10 years after diagnosis.
RESULTS: We included 15 032 patients with incident RA, 301 246 patients with DM and 75 160 persons from the GP. RA patients had an increased risk of HF [hazard ratio (HR) 1.51, 95% CI: 1.38, 1.64], MI (HR 1.58, 95% CI: 1.43, 1.74), percutaneous coronary intervention (PCI; HR 1.44, 95% CI: 1.27, 1.62), coronary artery bypass grafting (CABG; HR 1.30, 95% CI: 1.05, 1.62) and stroke (HR 1.22, 95% CI: 1.12-1.33) compared with the GP. However, the 10-year all-cause mortality was at the same level as observed in the GP. Cardiac death and MACE were increased in RA compared with the GP. When compared with patients with DM, RA patients had a lower adjusted risk of HF (HR 0.79, 95% CI: 0.73, 0.85), CABG (HR 0.62, 95% CI: 0.51, 0.76) and stroke (HR 0.82, 95% CI: 0.76, 0.89), and similar risk of MI and PCI. DM patients had the highest risk of 10-year mortality, cardiac death and MACE.
CONCLUSION: This study demonstrates that RA is associated with an increased risk of HF, MI, stroke and coronary revascularization than found in the GP but without reaching the risk levels observed in DM patients.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  death; diabetes mellitus; heart failure; ischaemic heart disease; rheumatoid arthritis; risk; stroke

Mesh:

Year:  2021        PMID: 32984893     DOI: 10.1093/rheumatology/keaa374

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

Review 1.  Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022.

Authors:  Bas Dijkshoorn; Reinder Raadsen; Michael T Nurmohamed
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

2.  Comment on: Vascular cell adhesion molecule-1 in rheumatoid arthritis.

Authors:  Ali S Jawad
Journal:  Saudi Med J       Date:  2021-08       Impact factor: 1.422

3.  Hotspots and future directions in rheumatoid arthritis-related cardiovascular disease: A scientometric and visualization study from 2001 to 2021 based on Web of Science.

Authors:  Pengfei Wen; Pan Luo; Binfei Zhang; Yakang Wang; Linjie Hao; Jun Wang; Jianbin Guo; Rui Liu; Yumin Zhang; Juan Chen
Journal:  Front Med (Lausanne)       Date:  2022-07-29

4.  Long-term outcomes in Rheumatoid Arthritis: Review of data from the 'Basildon Inflammatory Arthritis Cohort'.

Authors:  Kanishk Jain; Deena Laila; Anupama Nandagudi; Anurag Bharadwaj
Journal:  Rheumatol Adv Pract       Date:  2022-09-05

5.  Identifying hub circadian rhythm biomarkers and immune cell infiltration in rheumatoid arthritis.

Authors:  Pengfei Wen; Tao Ma; Binfei Zhang; Linjie Hao; Yakang Wang; Jianbin Guo; Wei Song; Jun Wang; Yumin Zhang
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

6.  Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.

Authors:  Tate M Johnson; Harlan R Sayles; Joshua F Baker; Michael D George; Punyasha Roul; Cheng Zheng; Brian Sauer; Katherine P Liao; Daniel R Anderson; Ted R Mikuls; Bryant R England
Journal:  Ann Rheum Dis       Date:  2021-05-28       Impact factor: 19.103

7.  All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019.

Authors:  Vasiliki-Kalliopi Bournia; George E Fragoulis; Panagiota Mitrou; Konstantinos Mathioudakis; Anastasios Tsolakidis; George Konstantonis; Georgia Vourli; Dimitrios Paraskevis; Maria G Tektonidou; Petros P Sfikakis
Journal:  RMD Open       Date:  2021-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.